cyclopropapyrroloindole: Clinical Trials

10 trials of cyclopropapyrroloindole, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 3 recruiting, 1 unknown. 5 Not applicable, 3 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 5
Phase 23Recruiting 2, Unknown 1
Phase 11Unknown 1
Phase 31Recruiting 1

Follow cyclopropapyrroloindole: new trials by email Literature Review of cyclopropapyrroloindole trials Research Report on cyclopropapyrroloindole

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Perceptions of High and Low Intensity Speech Intervention in Children With a Cleft Palate
High-intensity speech therapy for children with cleft palate, Low-intensity speech therapy for children with cleft palate - Cleft Lip and Palate, Cleft Palate Children
RecruitingUniversity Ghent452025-03-012026-08-24
A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer
BC1 cell line, Bria-OTS regimen and CPI (tislelizumab), Bria-OTS regimen and CPI (tislelizumab) expansion cohort - Breast Cancer, Breast Tumor
Phase 1 / Phase 2UnknownBriaCell Therapeutics Corporation182024-05-292024-08-26
Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs
Injection of drug-eluting microspheres with multiple drugs into solid tumors - Hepatocellular Carcinoma, Solid Tumor, Adult
Phase 2RecruitingSecond Affiliated Hospital of Guangzhou Medical University1002020-11-012024-08-21
Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
Checkpoint inhibitor (CPI) such as Pembrolizumab plus chemotherapy - Hepatocarcinoma, Lung Cancer
Phase 2 / Phase 3RecruitingSecond Affiliated Hospital of Guangzhou Medical University2002018-11-012024-06-25
CPI Training for Parents of Children With ASD
Parent-based Crisis Prevention Institute (CPI) physical management training program (P-CPI) - Autism Spectrum Disorder
Not applicableCompletedMassachusetts General Hospital812018-08-082021-06-29
Timing of Primary Surgery for Cleft Palate
primary surgery for cleft palate - Cleft Palate
Not applicableCompletedKevin Munro5582010-07-012026-09-02
Nutritional Evaluation of Canola Protein in Comparison With Soy Protein
Protein drink - protein isolate, Protein drink - protein hydrolyzate - Men
Not applicableCompletedUniversity of Jena282010-05-012015-03-05
Casinomacropeptide and Satiety
Whey, Whey-CMP, Control - Lack of Satiety, Excess Intake of Macronutrients
Not applicableCompletedUniversity of California, Davis202008-05-012017-08-14
A Proposal for a New Classification of Secondary Cleft Lip and Nose Deformities in Repaired Unilateral Cleft Lip
Patients with Unilateral Cleft Lip with or without Cleft Palate - Patients With Unilateral Cleft Lip With or Without Cleft Palate
CompletedSohag University3002006-01-012021-07-22
Smoking Cessation for HIV/AIDS Patients
Cell Phone Intervention, Recommended Standard of Care - Human Immunodeficiency Virus
Not applicableCompletedM.D. Anderson Cancer Center7062004-01-012016-02-26

Conditions studied

Breast Neoplasms (2)  ·  Carcinoma, Hepatocellular (2)  ·  Lung Neoplasms (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Aggression (1)  ·  Autism Spectrum Disorder (1)  ·  Cleft Lip (1)  ·  Cleft Palate (1)  ·  Colonic Neoplasms (1)  ·  Communication Disorders (1)  ·  Feeding and Eating Disorders (1)  ·  HIV Seropositivity (1)  ·  Head and Neck Neoplasms (1)  ·  Kidney Neoplasms (1)  ·  Melanoma (1)

Sponsors

Second Affiliated Hospital of Guangzhou Medical University (2)  ·  BriaCell Therapeutics Corporation (1)  ·  Kevin Munro (1)  ·  M.D. Anderson Cancer Center (1)  ·  Massachusetts General Hospital (1)  ·  Sohag University (1)  ·  University Ghent (1)  ·  University of California, Davis (1)  ·  University of Jena (1)

Countries

United States (4)  ·  China (2)  ·  Belgium (1)  ·  Brazil (1)  ·  Denmark (1)  ·  Germany (1)  ·  Norway (1)  ·  Sweden (1)  ·  United Kingdom (1)

Top investigators

Britt Burton-Freeman, PhD, MS (1)  ·  Damon Vidrine, MS, DRPH, BA (1)  ·  Gerhard Jahreis, Prof. Dr. (1)  ·  Giuseppe Del Priore, MD, MPH (1)  ·  Kevin J Munro (1)  ·  Kristiane Van Lierde, Professor (1)  ·  Lisa Nowinski, PhD (1)  ·  Victoria Chua-Alcala, MD (1)  ·  Zhenfeng Zhang, MD, PhD (1)  ·  Zhenfeng Zhang, MD,PhD (1)

Results publications

PMID 23260747, PMID 26666313, PMID 31300507, PMID 33397459, PMID 35100923, PMID 37646677, PMID 39101506, PMID 39791255, PMID 41459523, PMID 42568612

NIH funding

U01DE018837 (1)